BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1264 related articles for article (PubMed ID: 18283207)

  • 1. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
    Boutron I; Altman DG; Moher D; Schulz KF; Ravaud P;
    Ann Intern Med; 2017 Jul; 167(1):40-47. PubMed ID: 28630973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
    Altman DG; Schulz KF; Moher D; Egger M; Davidoff F; Elbourne D; Gøtzsche PC; Lang T;
    Ann Intern Med; 2001 Apr; 134(8):663-94. PubMed ID: 11304107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
    Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
    Zwarenstein M; Treweek S; Gagnier JJ; Altman DG; Tunis S; Haynes B; Oxman AD; Moher D; ;
    BMJ; 2008 Nov; 337():a2390. PubMed ID: 19001484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.
    Grant S; Mayo-Wilson E; Montgomery P; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):406. PubMed ID: 30060763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):112-121. PubMed ID: 28654980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    Ann Intern Med; 2006 Mar; 144(5):364-7. PubMed ID: 16520478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The REFLECT statement: reporting guidelines for Randomized Controlled Trials in livestock and food safety: explanation and elaboration.
    Sargeant JM; O'Connor AM; Gardner IA; Dickson JS; Torrence ME;
    Zoonoses Public Health; 2010 Mar; 57(2):105-36. PubMed ID: 20070652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
    Juszczak E; Altman DG; Hopewell S; Schulz K
    JAMA; 2019 Apr; 321(16):1610-1620. PubMed ID: 31012939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
    Pandis N; Chung B; Scherer RW; Elbourne D; Altman DG
    Br J Dermatol; 2019 Mar; 180(3):534-552. PubMed ID: 30609010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The REFLECT statement: reporting guidelines for randomized controlled trials in livestock and food safety: explanation and elaboration.
    Sargeant JM; O'Connor AM; Gardner IA; Dickson JS; Torrence ME; Dohoo IR; Lefebvre SL; Morley PS; Ramirez A; Snedeker K
    J Food Prot; 2010 Mar; 73(3):579-603. PubMed ID: 20202349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
    Moher D; Schulz KF; Altman DG;
    J Am Podiatr Med Assoc; 2001 Sep; 91(8):437-42. PubMed ID: 11574648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.